R 448
Latest Information Update: 12 May 2004
At a glance
- Originator Roche
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 12 May 2004 Discontinued - Phase-I for Chronic obstructive pulmonary disease (unspecified route)
- 30 Jun 2003 Phase-I clinical trials in Chronic obstructive pulmonary disease (unspecified route)